About
SATMEG Ventures develops new treatments for solid tumours by commercialising research from the Sahlgrenska Translational Melanoma Group (SATMEG) to provide tailored therapies for melanoma patients.
Explore SATMEG Ventures's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.